全文获取类型
收费全文 | 10816篇 |
免费 | 1228篇 |
国内免费 | 183篇 |
专业分类
耳鼻咽喉 | 204篇 |
儿科学 | 498篇 |
妇产科学 | 159篇 |
基础医学 | 803篇 |
口腔科学 | 294篇 |
临床医学 | 1862篇 |
内科学 | 1119篇 |
皮肤病学 | 172篇 |
神经病学 | 1247篇 |
特种医学 | 131篇 |
外国民族医学 | 1篇 |
外科学 | 801篇 |
综合类 | 1061篇 |
现状与发展 | 1篇 |
预防医学 | 1856篇 |
眼科学 | 191篇 |
药学 | 835篇 |
32篇 | |
中国医学 | 566篇 |
肿瘤学 | 394篇 |
出版年
2024年 | 56篇 |
2023年 | 271篇 |
2022年 | 430篇 |
2021年 | 606篇 |
2020年 | 605篇 |
2019年 | 590篇 |
2018年 | 586篇 |
2017年 | 559篇 |
2016年 | 457篇 |
2015年 | 433篇 |
2014年 | 675篇 |
2013年 | 933篇 |
2012年 | 622篇 |
2011年 | 639篇 |
2010年 | 505篇 |
2009年 | 514篇 |
2008年 | 535篇 |
2007年 | 513篇 |
2006年 | 457篇 |
2005年 | 363篇 |
2004年 | 258篇 |
2003年 | 224篇 |
2002年 | 225篇 |
2001年 | 184篇 |
2000年 | 164篇 |
1999年 | 106篇 |
1998年 | 94篇 |
1997年 | 84篇 |
1996年 | 79篇 |
1995年 | 67篇 |
1994年 | 60篇 |
1993年 | 56篇 |
1992年 | 48篇 |
1991年 | 44篇 |
1990年 | 22篇 |
1989年 | 33篇 |
1988年 | 21篇 |
1987年 | 20篇 |
1986年 | 9篇 |
1985年 | 19篇 |
1984年 | 15篇 |
1983年 | 6篇 |
1982年 | 4篇 |
1981年 | 5篇 |
1980年 | 12篇 |
1979年 | 4篇 |
1978年 | 5篇 |
1977年 | 3篇 |
1976年 | 2篇 |
1973年 | 2篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
《Journal of vascular and interventional radiology : JVIR》2022,33(4):359-367.e8
PurposeTo review and to compare indirectly the outcomes of minimally invasive therapies for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia.Materials and MethodsA literature search via Medline and Cochrane Central databases was completed for randomized control studies published between January 2000 to April 2020 for the following therapies: Rezum, Urolift, Aquablation, and prostatic artery embolization (PAE). Data on the following variables were included: International prostate symptom score (IPSS), maximum urinary flow rate, quality of life, and postvoid residual (PVR). Standard mean differences between treatments were compared through a meta-analysis using transurethral resection of the prostate (TURP) to assess differences in treatment effect.ResultsThere was no significant difference in outcomes between therapies for IPSS at the 3, 6, and 12-month follow ups. Although outcomes for Rezum were only available out to 3 months, there were no consistently significant differences in outcomes when comparing Aquablation versus PAE versus Rezum. TURP PVR was significantly better than Urolift at 3, 6, and 12 months. No significant differences in minor or major adverse events were noted.ConclusionAlthough significant differences in outcomes were limited, Aquablation and PAE were the most durable at 12 months. PAE has been well studied on multiple randomized control trials with minimal adverse events while Aquablation has limited high quality data and has been associated with bleeding-related complications. 相似文献
3.
4.
Chie Teramoto PHN RN MS Satoko Nagata PhD PHN RN Reiko Okamoto PhD PHN RN Ruriko Suzuki PHN RN MS Emiko Kishi PhD PHN RN Michie Nomura DSN PHN RN Noriko Jojima PHN RN MS Masumi Nishida PhD PHN RN Keiko Koide PhD PHN RN Emiko Kusano PhD PHN RN Saori Iwamoto PhD PHN RN Sachiyo Murashima PhD PHN RN 《Public health nursing (Boston, Mass.)》2015,32(6):654-661
5.
A mixed‐method study of effects of a therapeutic play intervention for children on parental anxiety and parents' perceptions of the intervention
下载免费PDF全文
![点击此处可从《Journal of advanced nursing》网站下载免费的PDF全文](/ch/ext_images/free.gif)
6.
Family-centered care (FCC) for sick newborns is emerging as a paradigmatic shift in the practice of facility-based newborn care. It seeks to transforming a provider-centered model into a client-centered one and thus build a new therapeutic alliance. FCC is the cornerstone of continuum of care, imparting caregiving competencies to parents/caregivers both within institutions as well as after the discharge. This has potential gains for the newborn, family members, and facility-level staff. The initial model piloted in tertiary-care settings is now undergoing translation at five sites across the country; the outcomes are keenly awaited. 相似文献
7.
8.
9.
10.
Paediatric palliative care and neurodisability are two relatively new, evolving paediatric sub-specialities that have increasing relevance in the current paediatric landscape. For many people palliative care has been synonymous with end of life care, but in paediatrics it encompasses much more and is for all children with life-threatening or life-limiting conditions, from the point of diagnosis. This breadth of focus is demonstrated well through the interface between paediatric palliative care and paediatric neurodisability. In this article we explore this unique interface through the three domains of complex symptom management, advanced care planning and end of life care. We describe the practicalities involved in all three areas and highlight the importance of early referral and the process of “dual” or “parallel” planning. We cover in more depth the specific management of the symptoms: dystonia/abnormalities of muscle tone, seizures, pain, agitation, secretions, respiratory failure, and gut failure. 相似文献